Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1971-3-23
|
pubmed:abstractText |
As it had been shown in previous trials that very small doses of pyrimethamine and sulfadoxine or dapsone were effective in eliminating Plasmodium falciparum in 2 or 3 days, small-scale field trials were carried out on children to investigate the efficacy of this combination of drugs in suppressing malaria.Doses of pyrimethamine 2 mg with sulfadoxine 40 mg, fortnightly, appeared to be completely successful in suppressing seasonal hyperendemic malaria in a group of 38 Gambian children over a 6-month period. On the other hand, pyrimethamine alone at the recommended dose failed to suppress falciparum malaria in some children of another group. Parasite resistance to the sulfonamide-pyrimethamine combination was not encountered nor was there any suggestion of toxicity. It is concluded that these drugs in combination could have a place in malaria chemoprophylaxis.
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/5313064-4237560,
http://linkedlifedata.com/resource/pubmed/commentcorrection/5313064-4867507,
http://linkedlifedata.com/resource/pubmed/commentcorrection/5313064-4893737,
http://linkedlifedata.com/resource/pubmed/commentcorrection/5313064-4922132,
http://linkedlifedata.com/resource/pubmed/commentcorrection/5313064-5335159,
http://linkedlifedata.com/resource/pubmed/commentcorrection/5313064-6019938
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0042-9686
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
43
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
513-20
|
pubmed:dateRevised |
2010-10-26
|
pubmed:meshHeading | |
pubmed:year |
1970
|
pubmed:articleTitle |
Malaria suppression with fortnightly doses of pyrimethamine with sulfadoxine in the Gambia.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial
|